Please assess the completion status of the following clinical trial:

Trial Title: Randomized Controlled Trial of Surfactant Administration by Laryngeal Mask Airway (LMA)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Birthweight \> 1200 grams~* Chronologic age \< 72 hours.~* Diagnosis of RDS by clinical and radiographic criteria.~* Treated with nasal CPAP and supplemental oxygen \> 30% and not requiring \> 60% FiO2 for longer than 30 minutes to maintain SaO2 88-95%.~* Parental consent.~Exclusion Criteria:~* Birthweight \< 1200 gms.~* Diagnosis other than RDS (e.g., meconium aspiration syndrome).~* Babies who require or have already had endotracheal intubation.~* Babies with congenital anomalies or conditions thought by the attending physician to contribute to respiratory symptoms and/or to restrict adequate spontaneous breathing (e.g., congenital heart disease, obtundation from maternal drugs, certain airway malformations, diaphragmatic hernia).

- Gender: ALL
- Minimum Age: None
- Maximum Age: 72 Hours
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Surfactant by LMA
- 2 (Type: OTHER): Standard of care

Based on this trial design, predict the completion outcome and termination type (if applicable).